Informatie:
Fout:
ID
28337
Beschrijving
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Visit: All Visits Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Trefwoorden
Versies (5)
- 30-11-17 30-11-17 -
- 30-11-17 30-11-17 -
- 07-12-17 07-12-17 -
- 10-12-17 10-12-17 -
- 04-01-18 04-01-18 -
Houder van rechten
Prof. Dr. med. Georg Heß
Geüploaded op
4 januari 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Signature GOAL Trial B-cell Lymphoma NCT02499003
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
confirmation patient information
Item
I have reviewed this eCRF and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient. All entries were made either by me or by a person under my supervision who has signed the Delegation and Signature Log
boolean
C0521091 (UMLS CUI [1,1])
C1955348 (UMLS CUI [1,2])
C1955348 (UMLS CUI [1,2])
Date of signature
Item
Date of signature
date
C0807937 (UMLS CUI [1])
Name of investigator
Item
Name of investigator
text
C2826892 (UMLS CUI [1])